Cargando…
COVID-19 and the liver-related deaths to come
Coronavirus disease 2019 (COVID-19) itself and/or the use of hepatotoxic drugs might negatively affect the course and management of patients with pre-existing chronic liver diseases. However, the greatest effect of COVID-19 on liver diseases will be indirect and delayed, resulting from the impending...
Autor principal: | Pawlotsky, Jean-Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288259/ https://www.ncbi.nlm.nih.gov/pubmed/32528138 http://dx.doi.org/10.1038/s41575-020-0328-2 |
Ejemplares similares
-
Will the COVID-19 crisis trigger a One Health coming-of-age?
por: de Garine-Wichatitsky, Michel, et al.
Publicado: (2020) -
Offline: COVID-19—what we can expect to come
por: Horton, Richard
Publicado: (2020) -
COVID-19 and the coming epidemic in US immigration detention centres
por: Meyer, Jaimie P, et al.
Publicado: (2020) -
Next-generation COVID-19 vaccines: here come the proteins
por: Blakney, Anna K, et al.
Publicado: (2021) -
Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality
por: Mehta, Puja, et al.
Publicado: (2022)